Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigrid Behr

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Pharmacology|April 1, 2011
Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case-control study in a large population-based German databaseKathrin Jobski, Sigrid Behr, Edeltraut Garbe
Pharmacoepidemiology and Drug Safety|February 4, 2012
Does additional confounder information alter the estimated risk of bleeding associated with phenprocoumon use--results of a two-phase studySigrid Behr, Walter Schill, Iris Pigeot
Pharmacoepidemiology and Drug Safety|June 29, 2010
Risk of intracerebral hemorrhage associated with phenprocoumon exposure: a nested case-control study in a large population-based German databaseSigrid Behr, Frank Andersohn, Edeltraut Garbe
Stroke|July 2, 2013
Risk of subarachnoid hemorrhage and early case fatality associated with outpatient antithrombotic drug useEdeltraut Garbe, Stefan H Kreisel, Sigrid Behr
Plos One|November 24, 2016
Risk of Stroke after Herpes Zoster - Evidence from a German Self-Controlled Case-Series StudyTania Schink, Sigrid Behr, Kathrin Thöne, et al.
Pharmaceutical Medicine|March 3, 2025
Disproportionality Analysis and Causal Inference in Drug SafetyEmil Scosyrev, Sigrid Behr, Devendra Jain, et al.
Pharmacoepidemiology and Drug Safety|April 21, 2012
3-year prevalence of alcohol-related disorders in German patients treated with high-potency opioidsKathrin Jobski, Ulrike Schmid, Sigrid Behr, et al.
Statistics in Medicine|January 12, 2018
A nonparametric method to detect increased frequencies of adverse drug reactions over timeGünter Heimann, Rossella Belleli, Jouni Kerman, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 28, 2017
A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USAThy P Do, Arpamas Seetasith, Rossella Belleli, et al.
JAMA Health Forum|August 17, 2022
International Country-Level Trends, Factors, and Disparities in Compassionate Use Access to Unlicensed Products for Patients With Serious Medical ConditionsPaul Aliu, Séverine Sarp, Ramona Reichenbach, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Pharmacology|April 1, 2011
Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case-control study in a large population-based German databaseKathrin Jobski, Sigrid Behr, Edeltraut Garbe
Pharmacoepidemiology and Drug Safety|February 4, 2012
Does additional confounder information alter the estimated risk of bleeding associated with phenprocoumon use--results of a two-phase studySigrid Behr, Walter Schill, Iris Pigeot
Pharmacoepidemiology and Drug Safety|June 29, 2010
Risk of intracerebral hemorrhage associated with phenprocoumon exposure: a nested case-control study in a large population-based German databaseSigrid Behr, Frank Andersohn, Edeltraut Garbe
Stroke|July 2, 2013
Risk of subarachnoid hemorrhage and early case fatality associated with outpatient antithrombotic drug useEdeltraut Garbe, Stefan H Kreisel, Sigrid Behr
Plos One|November 24, 2016
Risk of Stroke after Herpes Zoster - Evidence from a German Self-Controlled Case-Series StudyTania Schink, Sigrid Behr, Kathrin Thöne, et al.
Pharmaceutical Medicine|March 3, 2025
Disproportionality Analysis and Causal Inference in Drug SafetyEmil Scosyrev, Sigrid Behr, Devendra Jain, et al.
Pharmacoepidemiology and Drug Safety|April 21, 2012
3-year prevalence of alcohol-related disorders in German patients treated with high-potency opioidsKathrin Jobski, Ulrike Schmid, Sigrid Behr, et al.
Statistics in Medicine|January 12, 2018
A nonparametric method to detect increased frequencies of adverse drug reactions over timeGünter Heimann, Rossella Belleli, Jouni Kerman, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 28, 2017
A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USAThy P Do, Arpamas Seetasith, Rossella Belleli, et al.
JAMA Health Forum|August 17, 2022
International Country-Level Trends, Factors, and Disparities in Compassionate Use Access to Unlicensed Products for Patients With Serious Medical ConditionsPaul Aliu, Séverine Sarp, Ramona Reichenbach, et al.
Pageof 2